Growth Metrics

Travere Therapeutics (TVTX) EPS (Weighted Average and Diluted) (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -60.00%
Dec 31, 2025 -189.29%
Sep 30, 2025 300.00%
Jun 30, 2025 70.21%
Mar 31, 2025 32.86%
Dec 31, 2024 0.00%
Sep 30, 2024 23.08%
Jun 30, 2024 48.30%
Mar 31, 2024 -51.72%
Dec 31, 2023 -158.88%
Sep 30, 2023 274.34%
Jun 30, 2023 20.42%
Mar 31, 2023 -37.86%
Dec 31, 2022 5.50%
Sep 30, 2022 -3.81%
Jun 30, 2022 12.50%
Mar 31, 2022 -42.86%
Dec 31, 2021 -42.37%
Sep 30, 2021 7.81%
Jun 30, 2021 33.33%
Mar 31, 2021 62.06%
Dec 31, 2020 -475.00%
Sep 30, 2020 24.14%
Jun 30, 2020 -3,000.00%
Mar 31, 2020 102.80%
Mar 31, 2019 -450.00%
Dec 31, 2018 86.57%
Sep 30, 2018 -139.29%
Jun 30, 2018 -21.74%
Mar 31, 2018 16.36%
Dec 31, 2017 -19.57%
Sep 30, 2017 -35.29%
Jun 30, 2017 -6.25%
Mar 31, 2017 17.95%
Dec 31, 2016 61.00%
Sep 30, 2016 -170.27%
Jun 30, 2016 -362.50%
Mar 31, 2016 42.86%
Dec 31, 2015 -107.87%
Sep 30, 2015 343.84%
Jun 30, 2015 -155.30%
Mar 31, 2015 220.00%
Dec 31, 2014 -30.95%
Sep 30, 2014 -9.09%
Jun 30, 2014 76.31%
Mar 31, 2014 -296.34%
Dec 31, 2013 -15.49%
Sep 30, 2013 -73.17%